Handelsbanken Fonder Ab Accolade, Inc. Transaction History

Handelsbanken Fonder Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	BUY	$10.45 - $15.02 $22,624 - $32,518	2,165 Added 14.83%	16,765 $177,000
Q2 2023 Aug 02, 2023	SELL	$10.52 - $16.06 $26,300 - $40,150	-2,500 Reduced 14.62%	14,600 $197,000
Q4 2022 Feb 07, 2023	BUY	$7.19 - $13.16 $43,859 - $80,276	6,100 Added 55.45%	17,100 $133,000
Q1 2022 May 11, 2022	SELL	$12.92 - $27.18 $16,796 - $35,334	-1,300 Reduced 10.57%	11,000 $193,000
Q3 2021 Nov 10, 2021	BUY	$41.3 - $54.56 $61,949 - $81,840	1,500 Added 13.89%	12,300 $519,000
Q2 2021 Aug 03, 2021	BUY	$38.61 - $55.0 $416,988 - $594,000	10,800 New	10,800 $587,000

174

67.6M

181K

1.66M

Ticker ACCD
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 71,938,896
Market Cap $496M
Description
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.